Evidence map›Paper›PMID 40151902›Full record

ArticleJournal of global health2025

Implementation of a coach-supported mHealth intervention for dementia prevention in China: a qualitative study among Chinese participants and coaches in the PRODEMOS trial.

Jinxia Zhang, Marieke P Hoevenaar-Blom, Xuening Jian, Haifeng Hou, Siqi Ge, Carol Brayne, Esmé Eggink, Melanie Hafdi, Mingyue He, Guohua Wang and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Jinxia ZhangBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
Marieke P Hoevenaar-BlomDepartment of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Xuening JianBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
Haifeng HouSchool of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
Siqi GeDepartment of Neuroepidemiology, Beijing Neurosurgical Institute, Beijing, China.
Carol BrayneCambridge Public Health, University of Cambridge, Cambridge, UK.
Esmé EgginkDepartment of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Melanie HafdiDepartment of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Mingyue HeCentre for Cognitive Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Guohua WangThe Second Affiliated Hospital of Shandong First Medical University, Tai'an, Shandong, China.
Wenzhi WangDepartment of Neuroepidemiology, Beijing Neurosurgical Institute, Beijing, China.
Wei ZhangCentre for Cognitive Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yueyi YuInnovation Centre for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yixuan NiuDepartment of Geriatrics, The Second Medical Centre & National Clinical Research Centre for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Jihui LyuCentre for Cognitive Disorders, Beijing Geriatric Hospital, Beijing, China.
Libin SongComvee Research Institute, Fuzhou Comvee Network & Technology, Fuzhou, China.
Wei WangBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
Youxin WangBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
Eric P Moll van CharanteDepartment of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Manshu SongBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
PRODEMOS study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Modifiable risk factors have been linked to 45% of dementia cases. Mobile health (mHealth) interventions targeting lifestyle-related risk factors with remote coaching have the potential to reach underserved high-risk populations globally. To date, little is known about the implementation of such interventions in China. Methods: Fifty semi-structured interviews were conducted with 14 participants and 11 health coaches involved in the PRODEMOS trial. This trial investigated whether a coach-supported mHealth application intervention can reduce dementia risk in people aged 55-75 years with multiple risk factors. Interviews were conducted three months and 12-18 months into the intervention, focusing on implementation outcomes among Chinese participants using thematic analysis. Results: Participants found the PRODEMOS app easy to use and remote coaching convenient, although coach responses were sometimes perceived as slow due to not logging into the mHealth platform simultaneously, thus delaying text chat communication. The intervention's appropriateness was shaped by its effectiveness in enhancing health awareness and meeting participants' needs. Feasibility depended on integration into daily routines, participant progress, partner support, coach attention, smartphone literacy, and time availability. Challenges for the coaches included remote motivational interviewing and sustained participant-coach engagement, influenced by participant-coach relationships, social environment, and the COVID-19 pandemic. Participants generally adhered to goals, but fidelity varied. Integration into primary care was endorsed. Conclusions: This first qualitative study of the Chinese arm of the PRODEMOS intervention demonstrates that it is an acceptable and implementable approach for promoting lifestyle changes in individuals at increased risk of dementia. While coaching is crucial for sustained engagement, it presents challenges when delivered remotely. Despite significant variability in participants' adherence, positive feedback underscores its potential for integration into primary care and large-scale implementation, provided issues with coaching and engagement are addressed. These findings offer valuable insights for practitioners and policymakers seeking to incorporate mHealth solutions into public health strategies for dementia prevention. Registration: PRODEMOS: ISRCTN15986016.

Indexed as

DementiaMentoringTelemedicineAgedChinaEast Asian PeopleFemaleHumansInterviews as TopicMaleMiddle AgedMobile ApplicationsQualitative ResearchRisk Factors

Identifiers

PMID40151902
PMCPMC11950902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.